Journal article
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Brain (London, England : 1878), Vol.141(10), pp.2895-2907
10/01/2018
DOI: 10.1093/brain/awy238
PMCID: PMC6158742
PMID: 30252044
Abstract
The G(4)C(2)-repeat expansion C9orf72 is the most common known cause of amyotrophic lateral sclerosis and frontotemporal dementia. The high phenotypic heterogeneity of C9orf72 patients includes a wide range in age of onset, modifiers of which are largely unknown. Age of onset could be influenced by environmental and genetic factors both of which may trigger DNA methylation changes at CpG sites. We tested the hypothesis that age of onset in C9orf72 patients is associated with some common single nucleotide polymorphisms causing a gain or loss of CpG sites and thus resulting in DNA methylation alterations. Combined analyses of epigenetic and genetic data have the advantage of detecting functional variants with reduced likelihood of false negative results due to excessive correction for multiple testing in genome-wide association studies. First, we estimated the association between age of onset in C9orf72 patients (n = 46) and the DNA methylation levels at all 7603 CpG sites available on the 450k BeadChip that are mapped to common single nucleotide polymorphisms. This was followed by a genetic association study of the discovery (n = 144) and replication (n = 187) C9orf72 cohorts. We found that age of onset was reproducibly associated with polymorphisms within a 124.7kb linkage disequilibrium block tagged by top-significant variation, rs9357140, and containing two overlapping genes (LOC101929163 and C6orf10). A meta-analysis of all 331 C9orf72 carriers revealed that every A-allele of rs9357140 reduced hazard by 30% (P = 0.0002); and the median age of onset in AA-carriers was 6 years later than GG-carriers. In addition, we investigated a cohort of C9o7f72 negative patients (n = 2634) affected by frontotemporal dementia and/or amyotrophic lateral sclerosis; and also found that the AA-genotype of rs9357140 was associated with a later age of onset (adjusted P = 0.007 for recessive model). Phenotype analyses detected significant association only in the largest subgroup of patients with frontotemporal dementia (n = 2142, adjusted P = 0.01 for recessive model). Gene expression studies of frontal cortex tissues from 25 autopsy cases affected by amyotrophic lateral sclerosis revealed that the G-allele of rs9357140 is associated with increased brain expression of LOC101929163 (a non-coding RNA) and HLA-DRB1 (involved in initiating immune responses), while the A-allele is associated with their reduced expression. Our findings suggest that carriers of the rs9357140 GG-genotype (linked to an earlier age of onset) might be more prone to be in a pro-inflammatory state (e.g. by microglia) than AA-carriers. Further, investigating the functional links within the C6orf10/LOC101929163/HLA-DRB1 pathway will be critical to better define age-dependent pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.
Details
- Title: Subtitle
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
- Creators
- Ming Zhang - Tongji UniversityRaffaele Ferrari - National Hospital for Neurology and NeurosurgeryMaria Carmela Tartaglia - University of TorontoJulia Keith - Canada Research ChairsEzequiel I. Surace - Inst Invest Neurol Dr Raul Carrea FLENI, Dept Neuropatol, Mol Biol Lab, Buenos Aires, DF, ArgentinaUri Wolf - Canada Research ChairsChristine Sato - University of TorontoMark Grinberg - University of TorontoYan Liang - University of TorontoZhengrui Xi - University of TorontoKyle Dupont - University of TorontoPhilip McGoldrick - University of TorontoAnna Weichert - University of TorontoPaul M. McKeever - University of TorontoRaphael Schneider - University of TorontoMichael D. McCorkindale - National Hospital for Neurology and NeurosurgeryClaudia Manzoni - University of ReadingRosa Rademakers - Mayo Clinic in FloridaNeill R. Graff-Radford - Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USADennis W. Dickson - Mayo Clinic in FloridaJoseph E. Parisi - Mayo ClinicBradley F. Boeve - Mayo ClinicRonald C. Petersen - Mayo ClinicBruce L. Miller - University of California, San FranciscoWilliam W. Seeley - University of California, San FranciscoJohn C. van Swieten - Erasmus MCJeroen van Rooij - Erasmus MC, Dept Neurol, Rotterdam, NetherlandsYolande Pijnenburg - University of AmsterdamJulie van der Zee - University of AntwerpChristine Van Broeckhoven - University of AntwerpIsabelle Le Ber - Institut du CerveauVivianna Van Deerlin - Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USAEunRan Suh - Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USAJonathan D. Rohrer - UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, EnglandSimon Mead - MRC Prion UnitCaroline Graff - Karolinska InstitutetLinn Oijerstedt - Karolinska InstitutetStuart Pickering-Brown - University of ManchesterSara Rollinson - University of ManchesterGiacomina Rossi - Fondazione IRCCS Istituto Neurologico Carlo BestaFabrizio Tagliavini - Fondazione IRCCS Istituto Neurologico Carlo BestaWilliam S. Brooks - UNSW SydneyCarol Dobson-Stone - The University of SydneyGlenda M. Halliday - The University of SydneyJohn R. Hodges - The University of SydneyOlivier Piguet - The University of SydneyGiuliano Binetti - Centro San Giovanni di Dio FatebenefratelliLuisa Benussi - Centro San Giovanni di Dio FatebenefratelliRoberta Ghidoni - Centro San Giovanni di Dio FatebenefratelliBenedetta Nacmias - University of FlorenceSandro Sorbi - University of FlorenceAmalia C. Bruni - Azienda Sanit Prov Catanzaro, Reg Neurogenet Ctr, Lamezia Terme, ItalyDaniela Galimberti - Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoElio Scarpini - Fondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoInnocenzo Rainero - University of TurinElisa Rubino - University of TurinJordi Clarimon - Biomedical Research Networking Center on Neurodegenerative DiseasesAlberto Lleo - Biomedical Research Networking Center on Neurodegenerative DiseasesAgustin Ruiz - Universitat Internacional de CatalunyaIsabel Hernandez - Universitat Internacional de CatalunyaPau Pastor - Hosp Univ Mutua de Terrassa, Memory Disorders Unit, Dept Neurol, Barcelona, SpainMonica Diez-Fairen - Hosp Univ Mutua de Terrassa, Memory Disorders Unit, Dept Neurol, Barcelona, SpainBarbara Borroni - University of BresciaFlorence Pasquier - Université de LilleVincent Deramecourt - Université de LilleThibaud Lebouvier - Université de LilleRobert Perneczky - Technical University of MunichJanine Diehl-Schmid - Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, GermanyJordan Grafman - Northwestern UniversityEdward D. Huey - Columbia University Irving Medical CenterRichard Mayeux - Columbia University Irving Medical CenterMichael A. Nalls - National Institute on AgingDena Hernandez - National Institute on AgingAndrew Singleton - National Institute on AgingParastoo Momeni - RONAZhen Zeng - Merck & Co., Inc., Rahway, NJ, USAJohn Hardy - UCL, Dept Mol Neurosci, Inst Neurol, London, EnglandJanice Robertson - University of TorontoLorne Zinman - Sunnybrook Health Science CentreEkaterina Rogaeva - University of TorontoInternational FTD-Genomics Consortium (IFGC)Timothy Griffiths (Contributor) - Psychological and Brain Sciences
- Resource Type
- Journal article
- Publication Details
- Brain (London, England : 1878), Vol.141(10), pp.2895-2907
- DOI
- 10.1093/brain/awy238
- PMID
- 30252044
- PMCID
- PMC6158742
- NLM abbreviation
- Brain
- ISSN
- 0006-8950
- eISSN
- 1460-2156
- Publisher
- Oxford Univ Press
- Number of pages
- 13
- Grant note
- 521-2010-3134; 529-2014-7504; 2015-02926 / Swedish Research Council PI13/02434; PI16/01861 / Accion Estrategica en Salud, integrated in the Spanish National R + D + I Plan Gamla tjanarinnor ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion 284 / Alzheimer's Society ANR-PRTS PREV-DEMALS project BRC149/NS/MH / NIHR Rare Disease Translational Research Collaboration Stohnes foundation Methusalem Excellence Program 1079679; 1103258 / NHMRC; National Health & Medical Research Council (NHMRC) of Australia 733051042 / JPND PreFrontALS MR/M008525/1 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) Dementia foundation Sweden 115975 / European Union; European Union (EU) MC_UU_00005/12; MC_U105597119; G0502157; G0400074; G1100540; MC_UU_00024/1; MR/M023664/1; G0900652 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR; Ministry of Education, Universities and Research (MIUR) 733051024 / JPND RiMOD James Hunter ALS Initiative Argentine National Research Council (CONICET) (EIS) University of Antwerp Karolinska Institutet Ricerca Corrente, Italian Ministry of Health; Ministry of Health, Italy Stockholm County Council ANR-10-IAIHU-06 / Investissements d'avenir; Agence Nationale de la Recherche (ANR) 1138223 / National Health and Medical Research Council of Australia; National Health & Medical Research Council (NHMRC) of Australia ALS Canada Clinical Research Fellowship Brain Foundation Sweden P01 NS084974; P01 AG019724; P01-AG-017586 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA Swedish Brain Power Research Foundation Flanders (FWO); FWO Canadian Consortium on Neurodegeneration in Aging Flemish Government initiated Impulse Program on Networks for Dementia Research (VIND) Swedish FTD Initiative Assistance Publique-Hopitaux de Paris (Clinical Research and Development Department) RCAOM-12123 / FTLD-exome 1138223 / National Health & Medical Research Council of Australia (NHMRC); National Health & Medical Research Council (NHMRC) of Australia 2015.0722 / Fondazione CRF Fondo Europeo de Desarrollo Regional (FEDER- "Una manera de Hacer Europa"); European Union (EU) Alzheimer foundation Sweden MR/M023664/1 / MRC UK GENFI grant; UK Research & Innovation (UKRI); Medical Research Council UK (MRC) Programme Hospitalier de Recherche Clinique Temerty Family Foundation 733050103 / Memorabel-FTD RF08900000 / Italian Ministry of health; Ministry of Health, Italy ALS Canada-Brain Canada R35 NS097261; P50 AG016574; P01 NS084974 / National Institutes of Health (NIH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 10/01/2018
- Academic Unit
- Psychological and Brain Sciences
- Record Identifier
- 9984627187202771
Metrics
18 Record Views